Scapho 150mg Injection contains Secukinumab, is a biological medicine used in the treatment of various autoimmune conditions.

Brand Name: Scapho

Composition: Secukinumab

Mechanism of Action:

Secukinumab is a fully human monoclonal antibody that specifically binds to tumor necrosis factor-alpha (TNF-alpha), a substance in the body that plays a role in inflammation. Adalimumab lowers inflammation and modifies the immune response linked to autoimmune disorders by blocking TNF-alpha.

Uses:

• Rheumatoid Arthritis
• Juvenile Idiopathic Arthritis
•  Psoriatic Arthritis
• Ankylosing Spondylitis
• Plaque Psoriasis

Dosage and Administration:

The particular condition being treated determines the dosage. The first dose for many illnesses is usually 40 mg, given subcutaneously.

Side Effects:

• Injection site reactions (redness, swelling, itching)
• Headache
• Nausea
• Fatigue
• Rash
• Upper respiratory infections

Safety Advise:

Liver  

Keep an eye on your liver's enzyme levels because Secukinumab can have an impact on it. Kindly speak with your healthcare provider.

Kidney  

Information about the use of Scapho 150mg Injection in renal disease patients is limited. Kindly speak with your healthcare provider.

Pregnancy  

Unless directed by your physician, avoid using Scapho 150mg Injection while you are pregnant. Notify your doctor if you are expecting a child, are already pregnant, or want to get pregnant while receiving therapy. 

Breast Feeding  

Scapho 150mg It is possible to utilize injections while nursing. But let your healthcare provider know if you're nursing a baby.

Alcohol  

Alcohol use along with Scapho 150mg Injection may result in negative side effects. Kindly speak with your healthcare provider.

Storage:

Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze.

How to use this Medication?

Secukinumab injection products are available as solutions in vials, pens, and prefilled syringes for subcutaneous administration; your doctor will decide the appropriate dosage based on your age and condition. Make sure you carefully read the label on your prescription, schedule your injection days on a calendar, and take the drug exactly as prescribed—that is, without changing the dosage.

Secukinumab injection products won't heal your disease; they will only help control it. Even if you feel better, keep using injection products containing adalimumab. Adalimumab injectable products should not be stopped without first consulting your doctor.

References:

1.      Sanford M, McKeage K. Secukinumab: first global approval. Drugs. 2015 Feb;75:329-38.

2.      Blauvelt A. Safety of secukinumab in the treatment of psoriasis. Expert opinion on drug safety. 2016 Oct 2;15(10):1413-20.

3.      Blair HA. Secukinumab: a review in ankylosing spondylitis. Drugs. 2019 Mar 1;79(4):433-43.

4.      Aboobacker S, Kurn H, Al Aboud AM. Secukinumab.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Cipla Ltd

Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Country of origin: India